Revolutionizing Surgery: Remote Operations with SSI Mantra System

A Delhi-based cancer hospital conducted clinical trials enabling remote surgeries using the SSI Mantra Surgical Robotic System at Rajiv Gandhi Cancer Institute. The trials demonstrated the efficacy of remote surgical practices, reducing costs and increasing accessibility to specialized medical care.

In a groundbreaking advancement, a Delhi-based cancer hospital successfully conducted clinical trials using a surgical robotic system that allowed doctors to perform surgeries remotely. The announcement came on Wednesday.

The trials took place at the Rajiv Gandhi Cancer Institute and Research Centre, utilizing the SSI Mantra Surgical Robotic System. According to Sudhir Rawal, medical director and chief of genito-uro oncology at the institute, one of the most significant advantages of telesurgery is that superspecialists do not need to be physically present at the surgery location.

Rawal highlighted that any qualified surgeon can manage the surgery in the operating theatre while the superspecialists perform the surgery remotely. All six surgeries conducted, including those for urinary bladder carcinoma, nephrectomy, hysterectomy, and cystectomy, were completed without any technical or surgical complications, demonstrating the efficacy and safety of remote surgical practices.

(With inputs from agencies.)